Please login to the form below
Forixiga
This page shows the latest Forixiga news and features for those working in and with pharma, biotech and healthcare.
AZ gets US approval for diabetes combo Qtern
Qtern is a fixed dose combination product based on the active ingredients in AZ's DPP-4 inhibitor Onglyza (saxagliptin) and SGLT2 inhibitor Farxiga/Forixiga (dapagliflozin).
Latest news
-
EU clears AZ's FDA-rejected diabetes combination
Qtern combines the active ingredients in AZ's DPP-4 inhibitor Onglyza (saxagliptin) with SGLT2 inhibitor Farxiga/Forixiga (saxagliptin), and is the second drug of its type on the market after
-
FDA rejects AZ's diabetes combination
The combination of DPP-4 inhibitor saxagliptin - sold by AZ as Onglyza - and SGLT2 inhibitor dapagliflozin (marketed as Farxiga/Forixiga) is considered to be a key component of the company's
More from news
Approximately 1 fully matching, plus 2 partially matching documents found.
Featured jobs
- Account Manager / Senior Account Manager - Healthcare Advertisin...
-
Excellent Remuneration
- Account Director – London based Medical Communications Agency
-
Excellent Remuneration Package
-
Senior Medical Writer
-
Salary TBC
- Freelance Medical Writer - Healthcare Advertising - London
-
Employment Type:. Type of Job:. Region:. Salary:. 250 to 330 per day
- Experienced / Senior Account Director - Publications - London
-
Up to £80, 000 plus great benefits
- Account Manager, Medical Communications and Marketing
-
£30, 000 – £40, 000 benefits and bonus
- Project Manager - Digital Healthcare - London
-
Excellent Remuneration Package
- Science Writer, Healthcare Advertising Agency
-
£40, 000 - 45, 000 DOE benefits,
- Senior / Principal Medical Writer - MedComms - Home Based / Vari...
-
Excellent Remuneration Packages
-
Director – Healthcare PR
-
Salary TBC
- Senior Account Manager- Pharma and Life Scienes
-
Competitive salary and benefits
- Project Manager - Medical Communications – South Wales
-
Excellent Remuneration Package
- Editor – Medical Education Agency – Bucks
-
Salary TBC
-
Senior Medical Writer
-
Competitive salary and benefits
- Senior Account Director/ Associate Director- Pharma and Life Sci...
-
Competitive salary and benefits
-
Account Director, Medical Education
-
Salary TBC
Subscribe to our email news alerts
- With Spiriva under pressure, Boehringer moves to bolster pipeline
- Genfit claims FDA breakthrough status for liver disease drug
- Mereo’s shareholders back OncoMed takeover
- Lucid Group announces the appointment of new CFO
- From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
- Q&A: Niels Lund
PMHub
Oncosec
OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target...
Latest intelligence
- From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
- How pharma is progressing their commitment in patient engagement...
- Cuttsy+Cuttsy awarded CPD Platinum by the IPA
- Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
- Breaking Bad
- Six behaviours separate the good brand teams from the bad...
Quick links
Infographics
